Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.07. | Beta Bionics, Inc.: Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 | 2 | GlobeNewswire (USA) | ||
23.06. | BBNX Stock May Gain From Abbott Deal to Advance iLet Integration | 2 | Zacks | ||
BETA BIONICS Aktie jetzt für 0€ handeln | |||||
23.06. | Beta Bionics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.06. | Analysts expect Beta Bionics patch pump launch by 2027 | 4 | MassDevice | ||
19.06. | Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor | 2 | MassDevice | ||
19.06. | Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor | 213 | GlobeNewswire (Europe) | IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet... ► Artikel lesen | |
16.06. | Beta Bionics stock initiated with Buy rating at Truist Securities | 5 | Investing.com | ||
01.06. | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | 2 | Insider Monkey | ||
30.05. | Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein | 5 | Investing.com Deutsch | ||
30.05. | Goldman Sachs sets Beta Bionics stock at Neutral with $16 target | 2 | Investing.com | ||
07.05. | Beta Bionics Q1 2025 slides: raised guidance despite earnings miss | 3 | Investing.com | ||
06.05. | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M | 2 | Seeking Alpha | ||
06.05. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
06.05. | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 522 | GlobeNewswire (Europe) | IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results... ► Artikel lesen | |
16.04. | Beta Bionics, Inc.: Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 | 1 | GlobeNewswire (USA) | ||
09.04. | Beta Bionics, Inc.: Beta Bionics to Host Investor Event on June 22, 2025 | 2 | GlobeNewswire (USA) | ||
04.04. | Stifel maintains Buy rating on Beta Bionics stock, target at $25 | 6 | Investing.com | ||
28.03. | Beta Bionics, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
27.03. | Beta Bionics appoints new board member from Delcath Systems | 1 | Investing.com | ||
27.03. | Beta Bionics ernennt neues Vorstandsmitglied von Delcath Systems | 4 | Investing.com Deutsch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 41,110 | +0,86 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Fresenius von 51,00 auf 50,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Das Biopharma-Geschäft... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 45,690 | -0,24 % | Siemens Healthineers: Die Entscheidung rückt näher | Seit Ende Mai läuft die Siemens Healthineers-Aktie in einer engen Spanne seitwärts. Zuletzt wurde der Kurs durch ein stetes Für und Wider in diesem Käfig gehalten. Aber spätestens mit den näher rückenden... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 57,02 | -2,28 % | PROCEPT BioRobotics to Report Second Quarter 2025 Financial Results on August 6, 2025 | ||
INCANNEX HEALTHCARE | 0,815 | 0,00 % | Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) | NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing... ► Artikel lesen | |
GENEDX | 78,41 | +0,69 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,560 | +0,73 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC mit einem Kursziel von 41,50 Euro auf "Underweight" belassen. Analyst David Adlington passte seinen am Montag vorliegenden... ► Artikel lesen | |
PHETON | 22,620 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
TALKSPACE | 2,550 | +2,82 % | Talkspace Announces Fourth Quarter and Full Year 2024 Results | Full year 2024 total revenue grew 25% year-over-year to $187.6 millionFull year 2024 net income of $1.1 million and adjusted EBITDA1 of $7.0 million 4Q 2024 total revenue grew 15% year-over-year... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 12,485 | +0,69 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
PROGYNY | 22,930 | +4,23 % | Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 19,715 | -1,13 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
GLUCOTRACK | 7,970 | 0,00 % | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
GERRESHEIMER | 47,240 | -0,55 % | EQS-News: Gerresheimer AG: Gerresheimer erreicht A- im CDP-Rating | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer erreicht A- im CDP-Rating
15.07.2025 / 10:00 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 20,170 | +2,91 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
CARL ZEISS MEDITEC | 50,70 | 0,00 % | ANALYSE-FLASH: RBC lässt Carl Zeiss Meditec auf 'Sector Perform' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Die kanadische Bank RBC hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 60 Euro auf "Sector Perform" belassen. Analyst Jack Reynolds-Clark sieht laut seinem am... ► Artikel lesen |